Point prevalence survey of antibiotic use in Mexican secondary care hospitals
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0315925 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Federico A Zumaya-Estrada und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Public Health of Mexico, Center for Infectious Diseases Research, Cuernavaca, Morelos, Mexico. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Antimicrobial Stewardship. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer Inc.
Abstract (Originalsprache)
Introduction
Tackling the inertia of growing threat of antimicrobial resistance (AMR) requires changes in how antibiotics are prescribed and utilized. The monitoring of antimicrobial prescribing in hospitals is a critical component in optimizing antibiotic use. Point prevalence surveys (PPSs) enable the surveillance of antibiotic prescribing at the patient level in small hospitals that lack the resources to establish antimicrobial stewardship programs (ASP). In this study, we analyzed antibiotic use at two public secondary care hospitals in Mexico using PPSs.
Methods
Following WHO methodology, we conducted four cross-sectional PPSs on antibiotic use in two public secondary care facilities in Mexico: two surveys in a women’s specialty hospital (H1) and two in a general referral hospital (H2). We collected data from clinical records of all patients with active antibiotic prescriptions (APs) across the medical, surgical, and mixed (MIX) wards, and intensive care units (ICUs). Descriptive statistics were computed to analyze the PPSs data using Stata.
Results
The PPSs collected data on 127 patients, and 283 active APs. The prevalence of antibiotic use was 60.4% (H1, n = 29/48) and 70.5% (H2, n = 98/139). Antibiotics were more frequently used among patients in the MIX wards (H1: 87.5%, n = 14/16) and ICUs (H2: 90%, n = 9/10). The most frequent patient indications for antibiotic use were medical prophylaxis (H1: 51.7%, n = 15/29), community-acquired infections (H2: 42.9%, n = 42/98), and preoperative prophylaxis (H1: 27.6%, n = 8/29; H2: 23.5%, n = 23/98). The APs were mostly empirical (H1: 97%, n = 64/66; H2: 98.2%, n = 213/217), and parenterally administered (H1: 90.9%, n = 60/66; H2: 96.8%, n = 210/217). Most clinical records lacked documented post-prescription reviews (H1: 82.8%, n = 24/29; H2: 98%, n = 96/98). Preoperative prophylaxis was predominantly administered as multiple doses for more than one day. Penicillins with extended-spectrum (24.2%, n = 16/66), aminoglycosides (22.7%, n = 15/66), and first-generation cephalosporins (16.7%, n = 11/66) were the most prescribed antibiotic classes in H1, while third-generation cephalosporins (35%, n = 76/217), fluoroquinolones (14.3%, n = 31/217), and carbapenems (13.4%, n = 29/217) were the most prescribed in H2. No hospital had formally established ASP.
Conclusions
This study shows high prevalence rates of antibiotic use and variations in commonly prescribed antibiotic classes in public Mexican secondary care hospitals, along with shared practices in broad-spectrum antibiotic prescription. PPS-based surveillance enables the identification of specific targets to optimize antibiotic use according to the healthcare needs of patients in each hospital and facilitates comparative evaluations across hospitals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Institute of Public Health of Mexico, Center for Infectious Diseases Research, Cuernavaca, Morelos, Mexico.
- Pharmacovigilance Unit, General Hospital of Cuernavaca "Dr. José G. Parres", Health Services of Morelos, Cuernavaca, Morelos, Mexico.
- Department of Teaching, Research and Training, Women's Specialty Hospital, Health Services of Morelos, Yautepec de Zaragoza, Morelos, Mexico.
- National Institute of Public Health of Mexico, Center for Evaluation and Surveys Research, Cuernavaca, Morelos, Mexico.
ORCID-Profile: Federico A Zumaya-Estrada, Jesus Ulises Garza-Ramos
Förderung
- Pfizer Inc
Zitieren
APA
Zumaya-Estrada, F. A., Alpuche-Aranda, C. M., Huerta Icelo, H. I., Neri-Estrada, F. D., Calixto Silva, V. M., Quiroz Escoriza, H. E., Garza-Ramos, J. U., & Saturno-Hernandez, P. J. (2025). Point prevalence survey of antibiotic use in Mexican secondary care hospitals. PLOS ONE. https://doi.org/10.1371/journal.pone.0315925
Vancouver
Zumaya-Estrada FA, Alpuche-Aranda CM, Huerta Icelo HI, Neri-Estrada FD, Calixto Silva VM, Quiroz Escoriza HE, et al. Point prevalence survey of antibiotic use in Mexican secondary care hospitals. PLOS ONE. 2025. doi:10.1371/journal.pone.0315925
BibTeX
@article{ZumayaEstrada2025,
author = {Zumaya-Estrada, Federico A and Alpuche-Aranda, Celia M and Huerta Icelo, Hilda Ivonne and Neri-Estrada, Felipe D and Calixto Silva, Verónica M and Quiroz Escoriza, Haydee E and Garza-Ramos, Jesus Ulises and Saturno-Hernandez, Pedro J},
title = {Point prevalence survey of antibiotic use in Mexican secondary care hospitals},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0315925}
}
EUVIMED